These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29990525)

  • 1. A preclinical evaluation of a programmable CNT membrane device for transdermal nicotine delivery in hairless Guinea pigs.
    Gulati GK; Berger LR; Hinds BJ
    J Control Release; 2019 Jan; 293():135-143. PubMed ID: 29990525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmable carbon nanotube membrane-based transdermal nicotine delivery with microdialysis validation assay.
    Gulati GK; Chen T; Hinds BJ
    Nanomedicine; 2017 Jan; 13(1):1-9. PubMed ID: 27438911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmable transdermal delivery of nicotine in hairless guinea pigs using carbon nanotube membrane pumps.
    Paudel KS; Wu J; Hinds BJ; Stinchcomb AL
    J Pharm Sci; 2012 Oct; 101(10):3823-32. PubMed ID: 22806243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmable transdermal drug delivery of nicotine using carbon nanotube membranes.
    Wu J; Paudel KS; Strasinger C; Hammell D; Stinchcomb AL; Hinds BJ
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11698-702. PubMed ID: 20547880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrically controlled nicotine delivery through Carbon nanotube membranes via electrochemical oxidation and nanofluidically enhanced electroosmotic flow.
    Gulati GK; Hinds BJ
    Biomed Microdevices; 2021 Sep; 23(4):48. PubMed ID: 34562167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time controlled pulsatile transdermal delivery of nicotine: A phase I feasibility trial in male smokers.
    Hammann F; Kummer O; Guercioni S; Imanidis G; Drewe J
    J Control Release; 2016 Jun; 232():248-54. PubMed ID: 27090163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmable transdermal clonidine delivery through voltage-gated carbon nanotube membranes.
    Strasinger C; Paudel KS; Wu J; Hammell D; Pinninti RR; Hinds BJ; Stinchcomb A
    J Pharm Sci; 2014 Jun; 103(6):1829-38. PubMed ID: 24788096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal nicotine substitution: pharmacokinetics of nicotine and cotinine.
    Keller-Stanislawski B; Caspary S; Merz PG; Bonn R; Wolff M; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):417-21. PubMed ID: 8225689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varying nicotine patch dose and type of smoking cessation counseling.
    Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
    JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.
    Fiore MC; Kenford SL; Jorenby DE; Wetter DW; Smith SS; Baker TB
    Chest; 1994 Feb; 105(2):524-33. PubMed ID: 8306757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking Cessation Potential of Smartphone-Assisted Behavioral Therapy Coupled to Programmable Carbon Nanotube Membrane Nicotine Delivery Device.
    Gulati GK; Hinds BJ
    Crit Rev Ther Drug Carrier Syst; 2018; 35(6):495-520. PubMed ID: 30317967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdialysis in cutaneous pharmacology: kinetic analysis of transdermally delivered nicotine.
    Hegemann L; Forstinger C; Partsch B; Lagler I; Krotz S; Wolff K
    J Invest Dermatol; 1995 May; 104(5):839-43. PubMed ID: 7738365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels.
    Fredrickson PA; Hurt RD; Lee GM; Wingender L; Croghan IT; Lauger G; Gomez-Dahl L; Offord KP
    Psychopharmacology (Berl); 1995 Dec; 122(3):215-22. PubMed ID: 8748390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
    Dale LC; Hurt RD; Offord KP; Lawson GM; Croghan IT; Schroeder DR
    JAMA; 1995 Nov; 274(17):1353-8. PubMed ID: 7563559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
    Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
    JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy.
    Lawson GM; Hurt RD; Dale LC; Offord KP; Croghan IT; Schroeder DR; Jiang NS
    J Clin Pharmacol; 1998 Jun; 38(6):502-9. PubMed ID: 9650539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.
    Lerman C; Tyndale R; Patterson F; Wileyto EP; Shields PG; Pinto A; Benowitz N
    Clin Pharmacol Ther; 2006 Jun; 79(6):600-8. PubMed ID: 16765148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking.
    Benowitz NL; Zevin S; Jacob P
    Br J Clin Pharmacol; 1997 Mar; 43(3):259-67. PubMed ID: 9088580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
    Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
    Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
    Yudkin PL; Jones L; Lancaster T; Fowler GH
    Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.